Pharmacogenetic screening for susceptibility to fetal malformations in women. - Wikidata - awgldk - TriplyDB

Pharmacogenetic screening for susceptibility to fetal malformations in women.

Pharmacogenetic screening for susceptibility to fetal malformations in women.

http://www.wikidata.org/entity/Q33941950

about

Medical genetics: 1. Clinical teratology in the age of genomics.Drug target-gene signatures that predict teratogenicity are enriched for developmentally related genes.Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics.

P2860

Q33895431-EA06760B-5409-4993-B15B-F881C7A6706C Q35115594-F5063E35-604F-4701-AEEA-48237E34A71C Q36857493-855EEFBD-4682-4D47-ABD7-FD42EABA08AC

P2860

Pharmacogenetic screening for susceptibility to fetal malformations in women.

http://www.wikidata.org/entity/Q33941950

description

2000 nî lūn-bûn

@nan

2000 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Pharmacogenetic screening for susceptibility to fetal malformations in women.

@ast

Pharmacogenetic screening for susceptibility to fetal malformations in women.

@en

type

label

Pharmacogenetic screening for susceptibility to fetal malformations in women.

@ast

Pharmacogenetic screening for susceptibility to fetal malformations in women.

@en

prefLabel

Pharmacogenetic screening for susceptibility to fetal malformations in women.

@ast

Pharmacogenetic screening for susceptibility to fetal malformations in women.

@en

P1433

Q33941950-A6D83343-1CCC-4B65-B844-A208FBBDDD22

P1476

Q33941950-6C01DBEF-BBFD-4D84-A076-1AE653B80593

P2093

Q33941950-06DDEDC1-DFC7-4C02-8DAC-2F9E85C76C6C

Q33941950-137C98CA-15A3-4911-9BED-122EC543884D

Q33941950-5EB8C1E9-22BD-4D29-9B82-21E326A726E8

Q33941950-8EE8B10B-4B3E-4292-84F4-6592A7D4DEB7

Q33941950-9EA8009D-5DDD-4D7E-9EF3-CA32590F3B76

Q33941950-E01799B6-E2A6-411A-9323-390B5B76041F

P2860

Q33941950-0003A28D-9BF2-437E-9B54-2C2B6F9DF160

Q33941950-19FC1A6A-0E46-40C2-8949-EC4E4426D0A4

Q33941950-1C8876AF-1DDD-4D97-A8B0-B0956A50F427

Q33941950-27F9892C-6CBB-43DE-B1E3-D3F0124CA17B

Q33941950-34C37873-5353-44FF-88DA-21F7EDE32988

Q33941950-3F57795D-E654-4EC1-92B0-BC17C9103927

Q33941950-4081C35F-7556-4FEC-A6D8-637D01843230

Q33941950-47D73AA0-23E8-4299-B502-8E4C4FA11474

Q33941950-558596D5-0936-48A8-BCF5-802480E58525

Q33941950-5737952C-7A7E-4386-A73A-0E99BEA68858

P304

Q33941950-4244C287-B028-4108-8655-ABF593DC138D

P31

Q33941950-CBF455F0-A0BA-445B-8919-14989C95E2CB

P356

Q33941950-FBE830DC-84B0-44DC-96BC-686FE61EF8B0

P407

Q33941950-27D22CD8-D260-4F5F-9C8A-1123EF823E8C

P433

Q33941950-4EFFAB50-F80E-4932-95A5-1B540B917D11

P478

Q33941950-3399AE7B-4DE9-49B4-A53D-162FE911ED4D

P577

Q33941950-29C1D38B-9019-4F30-B21A-AB69255921F4

P5875

Q33941950-674FCA4A-F057-4D9B-A2AE-DDCFE0D32A09

P698

Q33941950-D3F7AB0A-12E8-4080-975C-CDE274B17500

P356

P1433

Annals of Pharmacotherapy

P1476

Pharmacogenetic screening for susceptibility to fetal malformations in women.

@en

P2093

A L Sherbondy

http://www.w3.org/2001/XMLSchema#string

D C Van Dyke

http://www.w3.org/2001/XMLSchema#string

D G Trembath

http://www.w3.org/2001/XMLSchema#string

J R Niebyl

http://www.w3.org/2001/XMLSchema#string

M J Berg

http://www.w3.org/2001/XMLSchema#string

V L Ellingrod

http://www.w3.org/2001/XMLSchema#string

P2860

Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects

Methionine decreases the embryotoxicity of sodium valproate in the rat: in vivo and in vitro observations

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.

Prenatal prediction of risk of the fetal hydantoin syndrome.

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.

The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids.

P304

639-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.19218

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12466649

http://www.w3.org/2001/XMLSchema#string

P698

10852093

http://www.w3.org/2001/XMLSchema#string